KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Amortizatization of Intangibles: 2018-2025

Historic Amortizatization of Intangibles for Xenon Pharmaceuticals (XENE) over the last 3 years, with Sep 2025 value amounting to $330,000.

  • Xenon Pharmaceuticals' Amortizatization of Intangibles rose 4.76% to $330,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 135.07%. This contributed to the annual value of $1.3 million for FY2024, which is 3.38% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Amortizatization of Intangibles of $330,000 as of Q3 2025, which was up 0.92% from $327,000 recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Amortizatization of Intangibles peaked at $330,000 during Q3 2025, and registered a low of -$4.6 million during Q4 2023.
  • For the 3-year period, Xenon Pharmaceuticals' Amortizatization of Intangibles averaged around -$300,375, with its median value being $317,000 (2024).
  • Data for Xenon Pharmaceuticals' Amortizatization of Intangibles shows a peak YoY surged of 106.88% (in 2024) over the last 5 years.
  • Over the past 3 years, Xenon Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at -$4.6 million in 2023, then spiked by 106.88% to $319,000 in 2024, then rose by 4.76% to $330,000 in 2025.
  • Its last three reported values are $330,000 in Q3 2025, $327,000 for Q2 2025, and $322,000 during Q1 2025.